Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
within the Antwerp University Hospital and the University of Antwerp, comprising over 50 scientists with a main goal to advance cancer treatment and to improve patient quality of life through development
-
, cutting-edge microscopy, immunology, technology development, and bioinformatics. VIB provides a highly interactive environment and ample training opportunities for its researchers. The VIB-UAntwerp Center
-
from established collaborations and access to centralized facilities with expertise in functional genomics and cell biology, proteomics, cutting-edge microscopy, immunology, technology development, and
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently
-
Knowledge of electronics, programmable logic, and processing systems is an advantage Strong analytical and programming skills are required (Python, VHDL, Matlab, and C/C++). Prior proven experience in data
-
and grippers offer improved safety and adaptability but introduce new challenges in design and control. Their development is still largely bio-inspired and trial-and-error based. Integrating flight and
-
research environment operating at an international level Participation in a large European collaboration State-of-the-art research facilities A dedicated training program to broaden your expertise and
-
approaches, developed and employed in the Malysheva Lab, are required to reveal these mechanisms. With the proposed project we aim to bridge this gap in our knowledge of cis-regulatory mechanisms underlying
-
. By evaluating different quenching mechanisms (e.g., proximity-based singlet oxygen quenching and wavelength-specific energy transfer), this project seeks to develop novel insights into molecular
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently